GMED · Globus Medical Inc

$77.00 -3.91 (-4.83%) At close · Jul 17

Market Cap

$10.45B

135,744,626

Trades by corporate insiders — officers, directors and holders of more than 10% of the shares — disclosed to the SEC on Forms 3, 4 and 5. Form 4 must be filed within two business days of the trade.

Insider Sentiment Score

Peer-relative 0–100 rank of how aggressively insiders accumulated over the trailing 90 days. See the full ranking.

Net buyers

-1

Net shares bought

-0.02%

Net buy value

-$2,019,072

Date	Insider	Role	Type	Security	Shares	Price	Value	After
2026-06-05	Davidar David D	Director	Convert↑	Class A Common Stock	25,000	$26.27	$656,750	535,175
2026-06-05	Davidar David D	Director	Sell↓ Filing footnotes — Class A Common Stock (Direct) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at a price range of $80.59 - $80.92, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares at each separate price within the range set forth in footnote (1) of this Form 4.	Class A Common Stock	25,000	$80.76	$2,019,073	510,175
2026-06-05	Davidar David D	Director	Convert↓ Filing footnotes — Stock Option (Right to Buy Class A Common Stock) (Direct) These options were granted on January 30, 2017 and are fully vested.	Stock Option (Right to Buy Class A Common Stock)	25,000	—	—	0
2026-06-04	RHOADS ANN D	Director	Convert↑	Class A Common Stock	25,000	$26.27	$656,750	40,384
2026-06-04	RHOADS ANN D	Director	Convert↓ Filing footnotes — Stock Option (Right to Buy Class A Common Stock) (Direct) These options were granted on January 30, 2017 and are fully vested.	Stock Option (Right to Buy Class A Common Stock)	25,000	—	—	0
2026-02-25	Huller Kelly	EVP, GC, Corporate Secretary	Sell↓ Filing footnotes — Class A Common Stock (Direct) This sale was effectuated pursuant to a Rule 10b5-1 trading plan dated November 12, 2025 executed by the reporting person.	Class A Common Stock	20,000	$94.50	$1,890,000	0
2026-02-25	Huller Kelly	EVP, GC, Corporate Secretary	Convert↓ Filing footnotes — Stock Option (Right to Buy Class A Common Stock) (Direct) These options were granted on January 22, 2019 and are fully vested.	Stock Option (Right to Buy Class A Common Stock)	20,000	—	—	20,000
2026-02-25	Huller Kelly	EVP, GC, Corporate Secretary	Convert↑	Class A Common Stock	20,000	$43.58	$871,600	20,000
2026-02-12	Huller Kelly	EVP, GC, Corporate Secretary	Convert↓ Filing footnotes — Stock Option (Right to Buy Class A Common Stock) (Direct) These options were granted on February 2, 2018 and are fully vested.	Stock Option (Right to Buy Class A Common Stock)	10,000	—	—	0
2026-02-12	Huller Kelly	EVP, GC, Corporate Secretary	Sell↓ Filing footnotes — Class A Common Stock (Direct) This sale was effectuated pursuant to a Rule 10b5-1 trading plan dated November 12, 2025 executed by the reporting person.	Class A Common Stock	10,000	$87.67	$876,700	0
2026-02-12	Huller Kelly	EVP, GC, Corporate Secretary	Convert↑	Class A Common Stock	10,000	$45.64	$456,400	10,000
2026-01-21	DeFord John A	Director	Award↑ Filing footnotes — Stock Option (Right to Buy Class A Common Stock) (Direct) These options were granted on January 21, 2026, and will vest on January 1, 2027.	Stock Option (Right to Buy Class A Common Stock)	15,000	—	—	15,000
2026-01-21	Paul David C	Director, Executive Chairman, 10% Owner	Award↑ Filing footnotes — Stock Option (Right to Buy Class A Common Stock) (Direct) These options were granted on January 21, 2026, and vest over a four-year period with 1/4 of the options vesting on January 1, 2027, then 1/48 of the options vesting each month thereafter.	Stock Option (Right to Buy Class A Common Stock)	100,000	—	—	100,000
2026-01-21	ZARRILLI STEPHEN T	Director	Award↑ Filing footnotes — Stock Option (Right to Buy Class A Common Stock) (Direct) These options were granted on January 21, 2026, and will vest on January 1, 2027.	Stock Option (Right to Buy Class A Common Stock)	15,000	—	—	15,000
2026-01-21	Lemaitre Dan	Director	Award↑ Filing footnotes — Stock Option (Right to Buy Class A Common Stock) (Direct) These options were granted on January 21, 2026, and will vest on January 1, 2027.	Stock Option (Right to Buy Class A Common Stock)	15,000	—	—	15,000
2026-01-21	Pfeil Keith W	Director, President, CEO	Award↑ Filing footnotes — Stock Option (Right to Buy Class A Common Stock) (Direct) These options were granted on January 21, 2026, and vest over a four-year period with 1/4 of the options vesting on January 1, 2027, and then 1/48 of the options vesting each month thereafter.	Stock Option (Right to Buy Class A Common Stock)	100,000	—	—	100,000
2026-01-21	Kline Kyle	Senior Vice President, CFO	Award↑ Filing footnotes — Stock Option (Right to Buy Class A Common Stock) (Direct) These options were granted on January 21, 2026, and vest over a four-year period with 1/4 of the options vesting on January 1, 2027, and then 1/48 of the options vesting each month thereafter.	Stock Option (Right to Buy Class A Common Stock)	30,000	—	—	30,000
2026-01-21	Norwalk Leslie V	Director	Award↑ Filing footnotes — Stock Option (Right to Buy Class A Common Stock) (Direct) These options were granted on January 21, 2026, and will vest on January 1, 2027.	Stock Option (Right to Buy Class A Common Stock)	15,000	—	—	15,000
2026-01-21	RHOADS ANN D	Director	Award↑ Filing footnotes — Stock Option (Right to Buy Class A Common Stock) (Direct) These options were granted on January 21, 2026, and will vest on January 1, 2027.	Stock Option (Right to Buy Class A Common Stock)	15,000	—	—	15,000
2026-01-21	Douglas Robert Andrew	Director	Award↑ Filing footnotes — Stock Option (Right to Buy Class A Common Stock) (Direct) These options were granted on January 21, 2026, and will vest on January 1, 2027.	Stock Option (Right to Buy Class A Common Stock)	15,000	—	—	15,000
2026-01-21	Davidar David D	Director	Award↑ Filing footnotes — Stock Option (Right to Buy Class A Common Stock) (Direct) These options were granted on January 21, 2026, and will vest on January 1, 2027.	Stock Option (Right to Buy Class A Common Stock)	15,000	—	—	15,000
2026-01-21	Wolterman Dan	Director	Award↑ Filing footnotes — Stock Option (Right to Buy Class A Common Stock) (Direct) These options were granted on January 21, 2026, and will vest on January 1, 2027.	Stock Option (Right to Buy Class A Common Stock)	15,000	—	—	15,000
2026-01-21	Huller Kelly	EVP, GC, Corporate Secretary	Award↑ Filing footnotes — Stock Option (Right to Buy Class A Common Stock) (Direct) These options were granted on January 21, 2026, and vest over a four-year period with 1/4 of the options vesting on January 1, 2027, and then 1/48 of the options vesting each month thereafter.	Stock Option (Right to Buy Class A Common Stock)	40,000	—	—	40,000
2026-01-21	TOBIN JAMES R	Director	Award↑ Filing footnotes — Stock Option (Right to Buy Class A Common Stock) (Direct) These options were granted on January 21, 2026, and will vest on January 1, 2027.	Stock Option (Right to Buy Class A Common Stock)	15,000	—	—	15,000
2026-01-08	Norwalk Leslie V	Director	Sell↓ Filing footnotes — Class A Common Stock (Direct) This sale was effectuated pursuant to a Rule 10b5-1 trading plan dated September 12, 2025 executed by the reporting person.	Class A Common Stock	2,000	$101.10	$202,200	10,419
2026-01-08	Kline Kyle	Senior Vice President, CFO	Convert↑	Class A Common Stock	3,594	$51.87	$186,421	3,594
2026-01-08	Kline Kyle	Senior Vice President, CFO	Sell↓ Filing footnotes — Class A Common Stock (Direct) This sale was effectuated pursuant to a Rule 10b5-1 trading plan dated August 25, 2025 executed by the reporting person.	Class A Common Stock	3,594	$101.10	$363,353	0
2026-01-08	Kline Kyle	Senior Vice President, CFO	Convert↓ Filing footnotes — Stock Option (Right to Buy Class A Common Stock) (Direct) These options were granted on March 14, 2024, and vest over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2025, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months.	Stock Option (Right to Buy Class A Common Stock)	3,594	—	—	3,906
2025-12-12	Norwalk Leslie V	Director	Sell↓ Filing footnotes — Class A Common Stock (Direct) This sale was effectuated pursuant to a Rule 10b5-1 Trading Plan dated September 12, 2025 executed by the reporting person.	Class A Common Stock	4,000	$88.85	$355,400	12,419
2025-12-08	Paul David C	Director, Executive Chairman, 10% Owner	Convert↓ Filing footnotes — Stock Option (Right to Buy Class A Common Stock) (Direct) These options were granted on January 25, 2016 and are fully vested.	Stock Option (Right to Buy Class A Common Stock)	34,375	—	—	0
2025-12-08	Paul David C	Director, Executive Chairman, 10% Owner	Convert↑	Class A Common Stock	34,375	$25.52	$877,250	60,417
2025-12-01	Kline Kyle	Senior Vice President, CFO	Convert↓ Filing footnotes — Stock Option (Right to Buy Class A Common Stock) (Direct) On December 3, 2025, the reporting person filed a Form 4 which inadvertently reported in Table II that 5,000 options were exercised prior to the sale of the underlying 4,896 shares of the issuer's Class A Common Stock that was reported in Table I. As correctly reported in this amendment, the reporting person exercised 4,896 options prior to the sale of the underlying 4,896 shares of the issuer's Class A Common Stock. These options were granted on January 27, 2022, and vest over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2023, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months.	Stock Option (Right to Buy Class A Common Stock)	4,896	—	—	104
2025-11-25	Huller Kelly	EVP, GC, Corporate Secretary	Sell↓ Filing footnotes — Class A Common Stock (Direct) This sale was effectuated pursuant to a Rule 10b5-1 trading plan dated December 4, 2024 executed by the reporting person.	Class A Common Stock	7,500	$90.00	$675,000	0
2025-11-25	Huller Kelly	EVP, GC, Corporate Secretary	Convert↓ Filing footnotes — Stock Option (Right to Buy Class A Common Stock) (Direct) These options were granted on February 2, 2017 and are fully vested.	Stock Option (Right to Buy Class A Common Stock)	7,500	—	—	0
2025-11-25	Huller Kelly	EVP, GC, Corporate Secretary	Convert↑	Class A Common Stock	7,500	$25.96	$194,700	7,500
2025-11-12	Davidar David D	Director	Sell↓ Filing footnotes — Class A Common Stock (Direct) The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at a price range of $86.00 - $86.01, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares at each separate price within the range set forth in footnote (1) of this Form 4.	Class A Common Stock	25,000	$86.00	$2,150,005	516,275
2025-11-12	Davidar David D	Director	Convert↑	Class A Common Stock	25,000	$25.52	$638,000	541,275
2025-11-12	Davidar David D	Director	Convert↓ Filing footnotes — Stock Option (Right to Buy Class A Common Stock) (Direct) These options were granted on January 25, 2016 and are fully vested.	Stock Option (Right to Buy Class A Common Stock)	25,000	—	—	0
2025-11-11	ZARRILLI STEPHEN T	Director	Convert↓ Filing footnotes — Stock Option (Right to Buy Class A Common Stock) (Direct) These options were granted on May 1, 2019 and are fully vested.	Stock Option (Right to Buy Class A Common Stock)	25,000	—	—	0
2025-11-11	ZARRILLI STEPHEN T	Director	Sell↓ Filing footnotes — Class A Common Stock (Direct) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $84.11 to $84.65, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (1) to this Form 4.	Class A Common Stock	25,000	$84.29	$2,107,258	0
2025-11-11	ZARRILLI STEPHEN T	Director	Convert↑	Class A Common Stock	25,000	$44.14	$1,103,500	25,000
2025-11-10	RHOADS ANN D	Director	Sell↓ Filing footnotes — Class A Common Stock (Direct) This sale was effected pursuant to a Rule 10b5-1 trading plan dated November 8, 2024 executed by the reporting person.	Class A Common Stock	2,000	$85.00	$170,000	15,384
2025-11-07	RHOADS ANN D	Director	Sell↓ Filing footnotes — Class A Common Stock (Direct) This sale was effected pursuant to a Rule 10b5-1 trading plan dated November 8, 2024 executed by the reporting person.	Class A Common Stock	8,000	$81.00	$648,000	17,384
2025-09-15	RHOADS ANN D	Director	Sell↓ Filing footnotes — Class A Common Stock (Direct) This sale was effected pursuant to a Rule 10b5-1 trading plan dated November 8, 2024 executed by the reporting person. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at a price range of $58.22-$58.81, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (2) to this Form 4.	Class A Common Stock	10,000	$58.46	$584,600	25,384
2025-07-18	Kline Kyle	Senior Vice President, CFO	Award↑ Filing footnotes — Stock Option (Right to Buy Class A Common Stock) (Direct) These options were granted on July 18, 2025, and vest over a four-year period with one-fourth (1/4) of the options granted vesting on July 18, 2026, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months.	Stock Option (Right to Buy Class A Common Stock)	20,909	—	—	20,909
2025-07-18	Pfeil Keith W	Director, President, CEO	Award↑ Filing footnotes — Stock Option (Right to Buy Class A Common Stock) (Direct) These options were granted on July 18, 2025, and vest over a four-year period with one-fourth (1/4) of the options granted vesting on July 18, 2026, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months.	Stock Option (Right to Buy Class A Common Stock)	40,000	—	—	40,000
2025-02-28	RHOADS ANN D	Director	Sell↓ Filing footnotes — Class A Common Stock (Direct) This sale was effected pursuant to a Rule 10b5-1 trading plan dated November 8, 2024 executed by the reporting person.	Class A Common Stock	7,500	$78.68	$590,100	35,384
2025-01-23	DeFord John A	Director	Award↑ Filing footnotes — Stock Option (Right to Buy Class A Common Stock) (Direct) These options were granted on January 23, 2025, and will vest on January 1, 2026.	Stock Option (Right to Buy Class A Common Stock)	15,000	—	—	15,000
2025-01-23	Douglas Robert Andrew	Director	Award↑ Filing footnotes — Stock Option (Right to Buy Class A Common Stock) (Direct) These options were granted on January 23, 2025, and will vest on January 1, 2026.	Stock Option (Right to Buy Class A Common Stock)	15,000	—	—	15,000
2025-01-23	Lemaitre Dan	Director	Award↑ Filing footnotes — Stock Option (Right to Buy Class A Common Stock) (Direct) These options were granted on January 23, 2025, and will vest on January 1, 2026.	Stock Option (Right to Buy Class A Common Stock)	15,000	—	—	15,000

Legend Buy — open-market purchase Sell — open-market sale ↑ Shares acquired ↓ Shares disposed (gift, conversion, tax…)

Showing 1–50 of 344 transactions

Key facts CIK 1237831 CUSIP 379577208 13F (30d) 66 filings 65 filers Visit website Investor relations